Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE).

Authors :: Ring J
Beyer K
Biedermann T
Bircher A
Fischer M
Fuchs T
Heller A
Hoffmann F
Huttegger I
Jakob T
Klimek L
Kopp MV
Kugler C
Lange L
Pfaar O
Rietschel E
Rueff F
Schnadt S
Seifert R
Stöcker B
Treudler R
Vogelberg C
Werfel T
Worm M
Sitter H
Brockow K
Source :: Allergo journal international [Allergo J Int] 2021; Vol. 30 (1), pp. 1-25. Date of Electronic Publication: 2021 Jan 28.
Publication Year :: 2021
Abstract: Competing Interests: Conflict of interestConflict of interest statements—in addition to the guideline report—can be found in tabular form and accessed on the AWMF website for the S2k guideline on “acute therapy and management of anaphylaxis: 2020 update” (www.awmf.org/leitlinien/detail/ll/061-025.html).